My latest paper, The Price of a Cure: Luxturna and the Economic Dilemmas of Precision Medicine, is in the Journal of Law, Medicine and Ethics. I discuss the economics of the pharmaceutical industry and the special issues that arise with targeted drugs that cure. We are going to get many more of these drugs in…
Expensive Pharmaceuticals for Targeted Diseases
Expensive Pharmaceuticals for Targeted Diseases
07 Nov 2026 Leave a comment
in applied price theory, entrepreneurship, health economics
Recent Comments